[go: up one dir, main page]

WO2008152444A3 - Foamable waterless compositions with modulating agents - Google Patents

Foamable waterless compositions with modulating agents Download PDF

Info

Publication number
WO2008152444A3
WO2008152444A3 PCT/IB2007/004628 IB2007004628W WO2008152444A3 WO 2008152444 A3 WO2008152444 A3 WO 2008152444A3 IB 2007004628 W IB2007004628 W IB 2007004628W WO 2008152444 A3 WO2008152444 A3 WO 2008152444A3
Authority
WO
WIPO (PCT)
Prior art keywords
modulating agents
foam
waterless
cosmetic
waterless compositions
Prior art date
Application number
PCT/IB2007/004628
Other languages
French (fr)
Other versions
WO2008152444A2 (en
Inventor
Dov Tamarkin
Meir Eini
Doron Friedman
Tal Berman
David Schuz
Original Assignee
Foamix Ltd
Dov Tamarkin
Meir Eini
Doron Friedman
Tal Berman
David Schuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foamix Ltd, Dov Tamarkin, Meir Eini, Doron Friedman, Tal Berman, David Schuz filed Critical Foamix Ltd
Priority to EP07874548A priority Critical patent/EP2097065A2/en
Priority to AU2007355106A priority patent/AU2007355106A1/en
Publication of WO2008152444A2 publication Critical patent/WO2008152444A2/en
Priority to IL198688A priority patent/IL198688A/en
Publication of WO2008152444A3 publication Critical patent/WO2008152444A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a waterless composition and foam as a vehicle in which an active pharmaceutical or cosmetic agent, when added is stable or stabilized by or its destabilization is impeded by the presence of a modulating agent. The pharmaceutical or cosmetic composition and foam, includes: a waterless solvent, a modulating agent and one or more active pharmaceutical or cosmetic agents. The present invention also relates to a method of treatment administering the waterless compostition and foam.
PCT/IB2007/004628 2006-11-29 2007-11-29 Foamable waterless compositions with modulating agents WO2008152444A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP07874548A EP2097065A2 (en) 2006-11-29 2007-11-29 Foamable waterless compositions with modulating agents
AU2007355106A AU2007355106A1 (en) 2006-11-29 2007-11-29 Foamable waterless compositions with modulating agents
IL198688A IL198688A (en) 2006-11-29 2009-05-11 Composition with modulating agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86162006P 2006-11-29 2006-11-29
US60/861,620 2006-11-29

Publications (2)

Publication Number Publication Date
WO2008152444A2 WO2008152444A2 (en) 2008-12-18
WO2008152444A3 true WO2008152444A3 (en) 2009-06-18

Family

ID=40130252

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/004628 WO2008152444A2 (en) 2006-11-29 2007-11-29 Foamable waterless compositions with modulating agents

Country Status (4)

Country Link
EP (1) EP2097065A2 (en)
AU (1) AU2007355106A1 (en)
IL (1) IL198688A (en)
WO (1) WO2008152444A2 (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US8507561B2 (en) 2009-01-22 2013-08-13 Absorption Pharmaceuticals, LLC Desensitizing drug product
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9248136B2 (en) 2011-11-23 2016-02-02 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10052386B2 (en) 2012-06-18 2018-08-21 Therapeuticsmd, Inc. Progesterone formulations
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2019175290A1 (en) 2018-03-13 2019-09-19 Beckley Canopy Therapeutics Limited Cannabis or cannabis derived compositions for promoting cessation of chemical dependence
US10471148B2 (en) 2012-06-18 2019-11-12 Therapeuticsmd, Inc. Progesterone formulations having a desirable PK profile
RU2762342C2 (en) * 2016-10-18 2021-12-20 Филип Моррис Продактс С.А. Ready-made composition for evaporation of electronic vaping device and electronic vaping device with such a composition

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
CA2513773C (en) 2003-01-24 2013-03-26 Connetics Australia Pty Ltd Clindamycin phosphate foam
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
JP5042209B2 (en) 2005-03-24 2012-10-03 ノーラブズ エービー Cosmetic treatment with nitric oxide, apparatus for performing the treatment, and method for manufacturing the same
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090558A2 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
CN102438590B (en) 2009-02-25 2013-07-10 施泰福研究澳大利亚有限公司 Topical foam composition
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2010130028A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
WO2011022680A2 (en) 2009-08-21 2011-02-24 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
EP4249001A3 (en) 2009-08-21 2023-11-29 Novan, Inc. Topical gels
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011121062A1 (en) 2010-03-31 2011-10-06 Helmut Vockner Composition for the treatment of periodontitis and other inflammatory infectious diseases
WO2011133217A1 (en) * 2010-04-21 2011-10-27 Pharmacline, Llc Topical drug delivery system with dual carriers
EP2579852B1 (en) 2010-06-11 2014-12-31 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
US8357422B2 (en) 2010-07-02 2013-01-22 Rbc Life Sciences, Inc. Dietary supplement
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
DK2651450T3 (en) * 2010-12-16 2016-03-14 Borje S Andersson Azole Pharmaceutical formulations for parenteral administration and methods for preparing and using these for the treatment of diseases that are sensitive to azole compounds
US8952057B2 (en) * 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
RU2587064C2 (en) * 2011-02-11 2016-06-10 Моберг Фарма Аб Novel antifungal composition
CA2834262C (en) 2011-04-28 2020-08-25 Borje S. Andersson Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
EP2729131B1 (en) 2011-07-05 2020-04-15 Novan, Inc. Topical compositions
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11077194B2 (en) 2012-03-14 2021-08-03 Novan, Inc. Nitric oxide releasing pharmaceutical compositions
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
TW201410244A (en) * 2012-08-13 2014-03-16 Teva Pharma Laquinimod for treatment of GABA mediated disorders
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
JP6513667B2 (en) 2013-08-08 2019-05-15 ノヴァン，インコーポレイテッド Topical composition and method of using the same
WO2016022170A1 (en) 2014-08-08 2016-02-11 Novan, Inc. Topical emulsions
JP2017516768A (en) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． Natural combination hormone replacement therapy and therapy
ES2759224T3 (en) * 2014-06-12 2020-05-08 Ceva Sante Animale Composite foam pheromone compositions
CN106659675B (en) 2014-07-11 2023-07-04 诺万公司 Topical antiviral compositions and methods of use thereof
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
WO2016018993A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
US10716305B2 (en) 2015-01-23 2020-07-21 Biocidium Biopharmaceuticals Inc. Anti-bacterial compositions
PT3310389T (en) 2015-06-18 2020-11-11 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
CA3002214C (en) 2015-11-03 2022-01-04 Zoetis Services Llc Sol-gel polymer composites and uses thereof
CN105424884B (en) * 2015-11-18 2017-04-05 中国海洋石油总公司 A kind of detection method of poly- table binary composite oil-displacing system concentration of component
WO2017151905A1 (en) 2016-03-02 2017-09-08 Novan, Inc. Compositions for treating inflammation and methods of treating the same
KR20220050236A (en) 2016-04-13 2022-04-22 노반, 인크. Compositions, Systems, Kits and Methods for Treating an Infection
GB201607814D0 (en) 2016-05-04 2016-06-15 5D Health Prot Group Ltd Anti-microbial compositions
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
US20180103681A1 (en) * 2016-10-18 2018-04-19 Altria Client Services Llc Methods and systems for increasing stability of the pre-vapor formulation of an e-vaping device
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
WO2019169221A1 (en) 2018-03-01 2019-09-06 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof
CN108949296B (en) * 2018-08-15 2021-11-05 江苏四新界面剂科技有限公司 Monocrystalline silicon cutting surfactant
GB201813876D0 (en) 2018-08-24 2018-10-10 Antibiotx As Treatment
WO2020089467A1 (en) 2018-11-02 2020-05-07 UNION therapeutics A/S Dosage regimen
BR112021008417A2 (en) 2018-11-02 2021-09-14 UNION therapeutics A/S HALOGENATED SALICYLANYLIDES TO TREAT DERMATITIS SYMPTOMS
DE102022116721A1 (en) 2022-07-05 2024-01-11 Paul Hartmann Ag Absorbent incontinence article as a disposable disposable product and method for producing the incontinence article
CN119367276B (en) * 2024-11-01 2025-08-19 重庆金佛山高等研究院 Antiallergic paste and preparation method and application thereof
CN119564838A (en) * 2025-02-06 2025-03-07 杭州纽龙日尚生物制品有限公司 Composition based on 2-oxo-glutaric acid and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933486A (en) * 1960-10-26 1963-08-08 Vantorex Ltd Improvements in or relating to aerosol foams
WO1991011991A1 (en) * 1990-02-09 1991-08-22 Kabi Pharmacia Ab Foamable composition for pharmaceutical use, use thereof and method of treatment
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
WO2008075207A2 (en) * 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933486A (en) * 1960-10-26 1963-08-08 Vantorex Ltd Improvements in or relating to aerosol foams
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
WO1991011991A1 (en) * 1990-02-09 1991-08-22 Kabi Pharmacia Ab Foamable composition for pharmaceutical use, use thereof and method of treatment
WO2008075207A2 (en) * 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US8703105B2 (en) 2003-08-04 2014-04-22 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8637577B2 (en) 2009-01-22 2014-01-28 Absorption Pharmaceuticals, LLC Desensitizing drug product
US8563616B2 (en) 2009-01-22 2013-10-22 Absorption Pharmaceuticals, LLC Desensitizing drug product
US8507561B2 (en) 2009-01-22 2013-08-13 Absorption Pharmaceuticals, LLC Desensitizing drug product
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US9248136B2 (en) 2011-11-23 2016-02-02 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10052386B2 (en) 2012-06-18 2018-08-21 Therapeuticsmd, Inc. Progesterone formulations
US10471148B2 (en) 2012-06-18 2019-11-12 Therapeuticsmd, Inc. Progesterone formulations having a desirable PK profile
US11033626B2 (en) 2012-06-18 2021-06-15 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11865179B2 (en) 2012-06-18 2024-01-09 Therapeuticsmd, Inc. Progesterone formulations having a desirable PK profile
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10912783B2 (en) 2015-07-23 2021-02-09 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US10532059B2 (en) 2016-04-01 2020-01-14 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
RU2762342C2 (en) * 2016-10-18 2021-12-20 Филип Моррис Продактс С.А. Ready-made composition for evaporation of electronic vaping device and electronic vaping device with such a composition
WO2019175290A1 (en) 2018-03-13 2019-09-19 Beckley Canopy Therapeutics Limited Cannabis or cannabis derived compositions for promoting cessation of chemical dependence

Also Published As

Publication number Publication date
AU2007355106A1 (en) 2008-12-18
IL198688A (en) 2015-06-30
WO2008152444A2 (en) 2008-12-18
IL198688A0 (en) 2010-02-17
EP2097065A2 (en) 2009-09-09

Similar Documents

Publication Publication Date Title
WO2008152444A3 (en) Foamable waterless compositions with modulating agents
UA89077C2 (en) PINOTVIRNI composition with a high content of alcohol and surfactants based on silicone, CONCENTRATE COMPOSITIONS, DOSAGE AND METHOD OF USING FOAM COMPOSITIONS, NEHERMETYZOVANYY FILLER, METHOD OF ALCOHOLIC COMPOSITION AND METHOD FOR FOAM FOAM APPLICATION FOR ALCOHOLIC SKIN FOR PERSONAL disinfection
WO2007137066A3 (en) HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
WO2007067504A3 (en) Lactam compounds and methods of using the same
WO2007081579A3 (en) Foam/spray producing compositions and dispensing system therefor
WO2009100441A3 (en) Depot formulations
WO2009120365A3 (en) Methods and compositions for the delivery of agents
WO2006069998A3 (en) Glycopyrrolate in cosmetic preparations
WO2006083630A3 (en) Diiodomethyl-p-tolylsulfone as a particulate dispersion in a liquid solvent in combination with an anti-dandruff active
WO2006037116A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2006020598A3 (en) Amido compounds and their use as pharmaceuticals
EP2070509A3 (en) The use of Myrica gale oil
WO2006002361A3 (en) 2-methylpropanamides and their use as pharmaceuticals
WO2009098595A3 (en) Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2011009436A3 (en) Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically
WO2006012226A3 (en) N-substituted piperidines and their use as pharmaceuticals
MX2009006140A (en) Microencapsulated delivery vehicle having an aqueous core.
WO2008018796A3 (en) Viscoelastic aqueous gels comprising microspheres
PL1962815T3 (en) Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
WO2007133751A3 (en) Base-stabilized polyorthoester formulations
WO2006004741A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
WO2007072201A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2008073332A3 (en) Creatine compositions for skin treatment
WO2006004684A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2007874548

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 198688

Country of ref document: IL

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007355106

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2403/KOLNP/2009

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2007355106

Country of ref document: AU

Date of ref document: 20071129

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07874548

Country of ref document: EP

Kind code of ref document: A2